Related Experiment Video
Updated: Apr 4, 2026

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents
Abstract:
The activity of serial concentrations of different antimicrobial agents on the multiplication of Legionella pneumophila within human monocyte-derived macrophages was studied. The results led to the definition of a minimal extracellular concentration inhibiting intracellular multiplication (MIEC). According to the MIECs, the antimicrobial agents tested were classified in three groups: very active (MIEC less than or equal to 0.06 microgram/ml), such as erythromycin, rifampin, and pefloxacin; active (1 microgram/ml greater than or equal to MIEC greater than or equal to 0.1 microgram/ml), such as sulfamethoxazole-trimethoprim or doxycycline; and ineffective, such as cefoxitin, which was not active within macrophages at as high as 64 micrograms/ml despite a low MIC (0.2 microgram/ml) on bacterial charcoal-yeast extract agar. The activity of netilmicin was difficult to assess because of its effect on extracellular legionellae. Combinations of erythromycin with rifampin and pefloxacin with erythromycin, rifampin, doxycycline, or netilmicin showed an additive effect and no antagonism. These results obtained in a cellular model are in agreement with the efficacy of antimicrobial agents in experimental infections and in Legionnaires disease. They sustain clinical interest in the new quinolones, such as pefloxacin, and in combinations of antimicrobial agents for the treatment of Legionnaires disease.
Insights
This study evaluated antimicrobial drugs against Legionella pneumophila inside human macrophages, defining a minimal extracellular concentration inhibiting intracellular multiplication (MIEC). Erythromycin, rifampin, and pefloxacin were very active, showing promise for treating Legionnaires disease.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Legionella pneumophila is an intracellular pathogen causing Legionnaires disease.
- Understanding antimicrobial activity within host cells is crucial for effective treatment.
- Macrophage models provide insights into drug efficacy against intracellular bacteria.
Purpose of the Study:
- To assess the activity of various antimicrobial agents against intracellular Legionella pneumophila multiplication.
- To define a minimal extracellular concentration inhibiting intracellular multiplication (MIEC) for different drugs.
- To evaluate the synergistic or antagonistic effects of antimicrobial combinations.
Main Methods:
- Culturing human monocyte-derived macrophages infected with Legionella pneumophila.
- Exposing infected macrophages to serial concentrations of different antimicrobial agents.
- Determining the minimal extracellular concentration inhibiting intracellular multiplication (MIEC) for each agent.
- Testing combinations of antimicrobial agents for additive or antagonistic effects.
Main Results:
- Antimicrobial agents were classified into very active (e.g., erythromycin, rifampin, pefloxacin), active (e.g., sulfamethoxazole-trimethoprim, doxycycline), and ineffective (e.g., cefoxitin) based on MIEC values.
- Erythromycin-rifampin and pefloxacin-containing combinations demonstrated additive effects without antagonism.
- Netilmicin's activity was challenging to ascertain due to its extracellular effects.
Conclusions:
- Pefloxacin and erythromycin show significant potential for treating Legionnaires disease due to their high activity against intracellular L. pneumophila.
- Antimicrobial combinations, particularly those including pefloxacin, offer additive benefits and warrant further clinical investigation.
- The cellular model effectively predicts antimicrobial efficacy in experimental infections and human cases of Legionnaires disease.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis

